97 related articles for article (PubMed ID: 26713365)
1. Heparanase augments inflammatory chemokine production from colorectal carcinoma cell lines.
Tsunekawa N; Higashi N; Kogane Y; Waki M; Shida H; Nishimura Y; Adachi H; Nakajima M; Irimura T
Biochem Biophys Res Commun; 2016 Jan; 469(4):878-83. PubMed ID: 26713365
[TBL] [Abstract][Full Text] [Related]
2. An iminosugar-based heparanase inhibitor heparastatin (SF4) suppresses infiltration of neutrophils and monocytes into inflamed dorsal air pouches.
Sue M; Higashi N; Shida H; Kogane Y; Nishimura Y; Adachi H; Kolaczkowska E; Kepka M; Nakajima M; Irimura T
Int Immunopharmacol; 2016 Jun; 35():15-21. PubMed ID: 27015605
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulfate E blocks enzymatic action of heparanase and heparanase-induced cellular responses.
Higashi N; Maeda R; Sesoko N; Isono M; Ishikawa S; Tani Y; Takahashi K; Oku T; Higashi K; Onishi S; Nakajima M; Irimura T
Biochem Biophys Res Commun; 2019 Nov; 520(1):152-158. PubMed ID: 31582210
[TBL] [Abstract][Full Text] [Related]
4. Keratinocytes-associated chemokines and enzymatically quiescent heparanase induce the binding of resting CD4+ T cells.
Hershkoviz R; Marikovsky M; Gilat D; Lider O
J Invest Dermatol; 1996 Feb; 106(2):243-8. PubMed ID: 8601723
[TBL] [Abstract][Full Text] [Related]
5. Regulation of platelet heparanase during inflammation: role of pH and proteinases.
Ihrcke NS; Parker W; Reissner KJ; Platt JL
J Cell Physiol; 1998 Jun; 175(3):255-67. PubMed ID: 9572470
[TBL] [Abstract][Full Text] [Related]
6. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
[TBL] [Abstract][Full Text] [Related]
7. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
8. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
9. Heparanase enzyme in chronic inflammatory bowel disease and colon cancer.
Hermano E; Lerner I; Elkin M
Cell Mol Life Sci; 2012 Aug; 69(15):2501-13. PubMed ID: 22331282
[TBL] [Abstract][Full Text] [Related]
10. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
11. Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence.
Doviner V; Maly B; Kaplan V; Gingis-Velitski S; Ilan N; Vlodavsky I; Sherman Y
Mod Pathol; 2006 Jun; 19(6):878-88. PubMed ID: 16607375
[TBL] [Abstract][Full Text] [Related]
12. Development of new methods for determining the heparanase enzymatic activity.
Melo CM; Tersariol IL; Nader HB; Pinhal MA; Lima MA
Carbohydr Res; 2015 Aug; 412():66-70. PubMed ID: 26062789
[TBL] [Abstract][Full Text] [Related]
13. Heparanase multiple effects in cancer.
Nadir Y; Brenner B
Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
15. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
16. Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage.
Kobayashi M; Naomoto Y; Nobuhisa T; Okawa T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Mizushima T; Matsuura H; Nakajima M; Nakagawa H; Rustgi A; Tanaka N
Differentiation; 2006 Jun; 74(5):235-43. PubMed ID: 16759289
[TBL] [Abstract][Full Text] [Related]
17. Human prostate carcinoma cells produce extracellular heparanase.
Kosir MA; Quinn CC; Zukowski KL; Grignon DJ; Ledbetter S
J Surg Res; 1997 Jan; 67(1):98-105. PubMed ID: 9070190
[TBL] [Abstract][Full Text] [Related]
18. Heparanase, tissue factor, and cancer.
Nadir Y; Vlodavsky I; Brenner B
Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
[TBL] [Abstract][Full Text] [Related]
19. Heparanase involvement in physiology and disease.
Nasser NJ
Cell Mol Life Sci; 2008 Jun; 65(11):1706-15. PubMed ID: 18425416
[TBL] [Abstract][Full Text] [Related]
20. Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progression.
Gerber U; Hoß SG; Shteingauz A; Jüngel E; Jakubzig B; Ilan N; Blaheta R; Schlesinger M; Vlodavsky I; Bendas G
Semin Thromb Hemost; 2015 Mar; 41(2):244-54. PubMed ID: 25682080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]